Oct 7, 2024 · Pseudoangiomatous stromal hyperplasia (PASH) is a benign, relatively uncommon form of stromal (mesenchymal) overgrowth within breast tissue that derives from a possible hormonal etiology. Typically affects women of reproductive age. It rarely affects males.

Apr 17, 2024 · Pseudoangiomatous stromal hyperplasia (PASH) is an incidental microscopic finding in up to 23% of breast surgical resections (Int J Surg 2011;9:20)

Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferation of the breast postulated to be hormonally induced. It is typically seen in premenopausal women or postmenopausal women taking hormone supplements. Imaging findings of PASH are nonspecific.

May 22, 2019 · Pseudoangiomatous stromal hyperplasia, referred to as “PASH” is a non-cancerous (benign) breast lesion that may (or may not) cause breast enlargement. PASH can sometimes be felt as a lump during a monthly self-breast exam, but is most often found during a routine mammogram. It can also be found during a biopsy for an unrelated breast condition.

Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative lesion of the breast that may present clinically as a mass and, from a histopathological point of view must be differentiated from low-grade angiosarcoma and phyllodes tumors.

Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal tumor-like lesion of the breast. It is commonly seen as incidental background changes of the intralobular stroma in biopsy specimens performed for other breast lesions.

Background: Pseudoangiomatous stromal hyperplasia (PASH) is a benign mesenchymal proliferative lesion of the breast. Owing to the rarity of PASH, the pathogenesis, clinical manifestation, and optimal treatment of this condition remain unclear. We aimed to clarify the appropriate management of PASH.

Pseudoangiomatous stromal hyperplasia (PASH) is an overgrowth of myofibroblastic cells in the breast. It has an appearance similar to fibroadenomatoid changes. [1] The diagnostic significance is currently uncertain, but it appears to be benign. There have been cases of PASH diagnosed where the tumors co-exist with breast cancer.

Apr 27, 2023 · Pseudoangiomatous stromal hyperplasia (PASH) is a benign breast pathology, which most commonly presents incidentally along with other breast pathologies. The etiology and pathogenesis of PASH are still unknown; however, there is some evidence suggesting PASH is hormone dependent.

Jan 1, 1996 · PURPOSE: To analyze the mammographic, ultrasonographic (US), and clinical patterns of pseudoangiomatous stromal hyperplasia (PASH). MATERIALS AND METHODS: Preoperative mammographic and US images, clinical records, and histologic assessments were reviewed in seven cases of PASH as the sole component or dominant stromal component of …